| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 09/20/2001 | WO2001027109A3 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 09/20/2001 | WO2001017961A3 Intermediates for the production of naphthyridine-3-carboxylic acid derivatives |
| 09/20/2001 | DE10013188A1 New hydrogenated perylenetetracarboxylic dianhydride, diimide and anhydride-imide derivatives are used as crystallization modifiers for organic pigments and in perylene pigment formulations |
| 09/20/2001 | DE10012373A1 Treating erectile dysfunction using new or known imidazo(1,5-a)pyrido(3,2-e)pyrazinone derivatives, as cGMP-selective phosphodiesterase V inhibitors free of cardiovascular side-effects |
| 09/20/2001 | CA2402549A1 Substituted beta-carbolines |
| 09/19/2001 | EP1134222A1 IMIDAZO[4,5-b]PYRIDINIUMMETHYL-CONTAINING CEPHEM COMPOUNDS HAVING BROAD ANTIBACTERIAL SPECTRUM |
| 09/19/2001 | EP1134221A1 Substituted beta-carbolines as lkB kinase inhibitors |
| 09/19/2001 | EP1133497A1 Crystal modification b of 8-cyano-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo 4.3.0]nonan -8-yl)-6- fluoro-1,4- dihydro-4- oxo-3-quinoline carboxylic acid |
| 09/19/2001 | EP1133496A1 Crystal modification a of 8-cyano-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo 4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro- 4-oxo-3- quinoline carboxylic acid |
| 09/19/2001 | EP1133495A1 Semi-hydrochloride of 8-cyan-1- cyclopropyl -7-(1s,6s-2 ,8-diazabicyclo 4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro -4-oxo-3- quinoline carboxylic acid |
| 09/19/2001 | EP1133493A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 09/19/2001 | EP1133480A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors |
| 09/19/2001 | EP1133295A1 Use of nicergoline for treating spasmodism |
| 09/19/2001 | EP1133293A1 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system |
| 09/19/2001 | CN1313859A Preparation of camptothecin and nothapodytine derivatives |
| 09/19/2001 | CN1313286A S type 4-substituted hydroxypyranoindolidine compound and its derivatives and preparation thereof |
| 09/19/2001 | CN1313280A Benzheterocyclic derivatives |
| 09/19/2001 | CN1071365C Process for preparing quinacridones |
| 09/19/2001 | CN1071329C Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/18/2001 | US6291672 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 09/18/2001 | US6291505 Pyrazole estrogen receptor agonist and antagonist |
| 09/18/2001 | US6291475 Bispidine antiarrhythmic compounds |
| 09/18/2001 | US6291474 Bicyclic amine derivatives |
| 09/18/2001 | US6291473 Treating anxiety, depression, post-traumatic stress disorder, inflammatory diseases, obesity, in mammals |
| 09/18/2001 | US6291469 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 09/18/2001 | US6291461 Stephacidin antitumor antibiotics |
| 09/18/2001 | US6291447 Inhibiting the g2 checkpoint in a cell |
| 09/18/2001 | US6291162 Determining amount of lactamase activity; transfecting cells with a nucleic acid having an expression control sequence linked to a secretion defective sequence; mixing cells with lactamase substrate; determine amount of cleaved substrate |
| 09/18/2001 | CA2236814C Quinoline and quinazoline compounds useful in therapy |
| 09/14/2001 | CA2339677A1 Product for the treatment of erectile dysfunction and its use |
| 09/13/2001 | WO2001066548A1 New aza-indolyl derivatives |
| 09/13/2001 | WO2001066545A2 1,8-NAPHTHALIMIDE IMIDAZO[4,5,1-de]ACRIDONES WITH ANTI-TUMOR ACTIVITY |
| 09/13/2001 | WO2001066544A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 09/13/2001 | WO2001066526A1 Ester derivatives of dimethylpropionic acid and pharmacetuical compositions containing them |
| 09/13/2001 | WO2001066525A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 09/13/2001 | WO2001066143A1 Vasoactive agents |
| 09/13/2001 | WO2001028993A3 Tyrosine kinase inhibitors |
| 09/13/2001 | WO2001009138A3 Chemokine receptor antagonists and methods of use therefor |
| 09/13/2001 | WO2000059886A3 Benzimidazole abd imidazolophyridine derivaties, their preparation and their use as selective modulators of bradykinin b2 (=bk-2) receptors |
| 09/13/2001 | WO2000056302A9 Vanadium (iv) complexes containing catacholate ligand and having spermicidal activity |
| 09/13/2001 | US20010021708 Acylurea compound containing imidazolidine ring |
| 09/13/2001 | CA2402179A1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 09/13/2001 | CA2402096A1 Vasoactive agents |
| 09/13/2001 | CA2401524A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 09/13/2001 | CA2399111A1 New aza-indolyl derivatives |
| 09/12/2001 | EP1132389A1 New aza-indolyl derivatives for the treatment of obesity |
| 09/12/2001 | EP1132388A2 Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 09/12/2001 | EP1132381A1 Ester derivatives of dimethylpropionic acid and pharmaceutical compositions containing them |
| 09/12/2001 | EP1132374A2 Bis-o-aminophenols and o-aminophenolcarboxylic acids |
| 09/12/2001 | EP1131322A2 Dihydropyridine compounds and methods of use |
| 09/12/2001 | EP1131306A2 Isoxazoline fibrinogen receptor antagonists |
| 09/12/2001 | EP1131295A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 09/12/2001 | CN1312812A Muscarinic agonists and antagonists |
| 09/12/2001 | CN1312810A Substituted 1,8-naphthyridin-4(1H)-ones as phosphodiesterase 4 inhibitors |
| 09/12/2001 | CN1312806A Prodrugs of proton pump inhibitors |
| 09/12/2001 | CN1070861C Bicyclic amidine and its use as catalyst |
| 09/12/2001 | CN1070856C Thiazole derivative |
| 09/12/2001 | CN1070855C 4-thiocarbamoyl-1-(3-pyrazoly)-pyrazoles and their use as herbicides |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6288232 Synthesis of pyrazolinylnaphthalic acid derivatives |
| 09/11/2001 | US6288229 Ruthenium complex having di or tetrapyridophenazine ligand useful for use as luminescent material |
| 09/11/2001 | US6288123 Therapeutic guanidines |
| 09/11/2001 | US6288092 Triaryl compounds |
| 09/11/2001 | US6288084 Administering comounds such as 4-(4-chlorophenyl)-1-(4-(3-methoxyphenyl)-4-(3-pyridinyl)-3 -butenyl)piperidin-4-ol to treat diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/11/2001 | US6288083 Chemokine receptor antagonists and methods of use therefor |
| 09/11/2001 | US6288078 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/11/2001 | US6288055 Analgesic agents |
| 09/11/2001 | CA2209422C 4-amino-3-acylnaphthyridine derivatives |
| 09/09/2001 | CA2575854A1 Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 09/07/2001 | WO2001064681A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 09/07/2001 | WO2001064676A2 INHIBITORS OF p38-α KINASE |
| 09/07/2001 | WO2001064674A1 2,4-disubstituted thiazolyl derivatives |
| 09/07/2001 | WO2001064670A1 Novel cyclic amide derivatives |
| 09/07/2001 | WO2001064655A1 2, 4-di(hetero-)arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 09/07/2001 | WO2001019823A3 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 09/07/2001 | WO2001010862A3 Substituted heterocyclybenzofuranes |
| 09/07/2001 | WO2001010861A3 Substituted heterocyclyl-2h-chromenes |
| 09/07/2001 | WO2001007432A8 Aminopiperidine derivatives as antibacterials |
| 09/07/2001 | CA2400649A1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 09/07/2001 | CA2398685A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 09/06/2001 | US20010020035 Certain fused pyrrolecarboxamides a new class of gaba brain receptor |
| 09/06/2001 | US20010020017 Autoimmune disease; antiinflammatory agents; antiproliferatory agents |
| 09/05/2001 | EP1130021A2 Pyrrolopyridinium derivatives |
| 09/05/2001 | EP1130015A1 Pyridazinone derivatives |
| 09/05/2001 | EP1129691A2 Compositions for dyeing keratinous fibers containing indolizine derivatives and dyeing method using same |
| 09/05/2001 | EP1129690A2 Keratin fibre dye compositions containing indolizine cationic derivatives and dyeing method |
| 09/05/2001 | EP1129096A2 Crf receptor antagonists and methods relating thereto |
| 09/05/2001 | EP1129091A2 Crf receptor antagonists and methods relating thereto |
| 09/05/2001 | EP1129090A1 PENTAAZA-CYCLOPENTA A]NAPHTHALENE DERIVATIVES AS LIGANDS FOR GABA A? $g(a)5 RECEPTORS |
| 09/05/2001 | EP1129089A1 Spiro-indolines as y5 receptor antagonists |
| 09/05/2001 | EP1129075A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
| 09/05/2001 | EP1128831A1 Pharmaceutical moxifloxacin preparation |
| 09/05/2001 | EP0828740B1 2-azabicyclo[2.2.1]heptane derivatives, preparation and application thereof |
| 09/05/2001 | EP0807112B1 Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials |
| 09/05/2001 | EP0726269B1 Quinolinecarboxylic acid derivatives and salts thereof |
| 09/05/2001 | CN1311789A Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity |
| 09/05/2001 | CN1311777A High affinity ligands for nociceptin receptor ORL-1 |
| 09/05/2001 | CN1070492C Tetracylic derivatives, process for prepn. of same and use |
| 09/05/2001 | CN1070489C Process for synthesis of substituted sulphoxides |
| 09/05/2001 | CN1070488C Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria |